Healthcare giant Johnson & Johnson (J&J) is taking its $1bn US buying business back to J3, a J&J-dedicated unit of IPG’s UM that currently handles its planning.
A little over a year ago the company moved its US buying business to Omnicom’s OMD from J3.
The company said in a statement that since customer and consumer insights and expectations for its brands are evolving both regionally and globally, it continually evaluates the resources required to meet needs and support growth opportunities.
“After careful consideration, we have decided to reintegrate our U.S. media buying with J3 for our consumer, pharmaceutical and medical device brands. Omnicom and OMD remain important partners for us around the world, delivering outstanding work that drives our business,” it said.
The move comes after the company began an international media review earlier this year.
